Insulin Resistance Syndrome
14
3
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
80.0%
-6.5% vs benchmark
21%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.
Gummy Candies With Maqui Berry
ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
Causal Mechanisms in Adolescent Arterial Stiffness
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
Aerobic and Strength Training With Caloric Restriction on Insulin Resistance in Obese Premenopausal Women
Effect of Konjac-mannan in Individuals With Insulin-Resistance Syndrome